Extortion group n0n claims 1.2 million patient records tied to Eli Lilly
Lilly says an internal investigation found no unauthorized access to its own systems, and the records are not identified as its patients. The claim lands on a third-party data vendor, and LLY has closed lower three sessions straight.
Vincent Jiangthree-minute read
Eli Lilly−2.82% — Eli Lilly, down 2.82 percent today closed at $1,382.75 on November 18, down 2.32% for a third straight session, while an extortion group called n0n advertised records for about 1.2 million patients: payer, copay and diagnosis fields, plus a prescriber master file holding names, addresses and 7.6 million National Provider Identifier numbers 12.
The files sit with a third-party information provider that sells Lilly anonymized prescribing data. They are not identified as Lilly patients, and Lilly's internal investigation found no unauthorized access to its own systems 2. Vertex and Vir Biotechnology, named on the same vendor, found no compromise of their systems or patient data; Verastem did not respond 2.
The published output is thousands of rows, not millions
The record undercuts the ransom note. When n0n's 48-hour deadlines expired, the group published roughly 2,000 Mastercard−2.62% — Mastercard, down 2.62 percent today entries in a 280KB file so malformed that several people's details share single rows, which security researcher Aras Nazarovas, who examined it, called likely test data 3.
Then came about 6,000 Visa premium-card customers, traced to a marketing platform in Asia-Pacific 4, and about 16,000 JPMorgan customer emails plus 124 staff addresses in a 502KB file, all tied to the invitation-only Reserve card, which typically asks for $10 million in managed assets 5.
The same file formatting runs through all three dumps, pointing to one shared third party rather than three broken institutions 3. On November 19 JPMorgan−1.32% — JPMorgan, down 1.32 percent today said vendors serving the firm were attacked and that marketing data, possibly customer names and email addresses, was taken 6.
n0n's three published dumps total about 24,000 records
Thousands of rows published against claims of millions
Data
| Records published | |
|---|---|
| Mastercard | 2,000 |
| Visa | 6,000 |
| JPMorgan | 16,000 |
The expensive fact is price, not phishing
Lilly's costly number this quarter was realized price, not a leak. Revenue rose 39% to $24.4 billion on 53% volume growth that absorbed a 15% fall in realized prices, and management lifted full-year revenue guidance to $91–92 billion 17, the same squeeze The Inference tracked when Novo beat tirzepatide head-to-head in September. n0n's medical claim totals 8.8 million records, more than 350 times the 24,000 rows the group has actually published across three banks. The ransom note says millions; the receipts say thousands, and most are garbled.
Lilly's quarterly revenue is up 80% in eight quarters, to $24.4 billion
The stock fell three days on a vendor claim; revenue grew 39% last quarter
Data
| Revenue | |
|---|---|
| Q4 '24 | $13.53B |
| Q1 '25 | $12.73B |
| Q2 '25 | $15.56B |
| Q3 '25 | $17.6B |
| Q4 '25 | $19.29B |
| Q1 '26 | $19.8B |
| Q2 '26 | $22.97B |
| Q3 '26 | $24.4B |
The vendor's name is the missing piece
n0n, tracked since September and rated likely Russia-based by SOCRadar, claims leaks on at least 107 companies; none has confirmed a breach of its own systems, and the only confirmed casualty so far is the vendor layer itself, where Expedia has already acknowledged a supply-chain attack through an outside data platform 2. Watch for the vendor's name, for a Lilly-linked dump with real rows in it, and for pricing detail at Lilly's December 7 Innovation Day 1. The hack is real. Every row published so far belongs to someone else.
Get Security by email, free
The breaches, flaws and security vendors AI is putting to the test. In our daily email, every weekday.






Reader comments
0 comments